Document
AttH_PIA CID, Reye Syndrome, Kawasaki Syndrome
ICR 201901-0920-013 · OMB 0920-0009 · Object 88879101.
⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0920-0009 can be found here:
Document [pdf]
Download: pdf | txt
Save Privacy Impact Assessment Form v 1.21 Status Form Number Form Date Question Answer 1 OPDIV: CDC 2 PIA Unique Identifier: TBD 2a Name: 24 National Disease Data (NDSP) General Support System (GSS) Major Application 3 Minor Application (stand-alone) The subject of this PIA is which of the following? Minor Application (child) Electronic Information Collection Unknown 3a Identify the Enterprise Performance Lifecycle Phase of the system. Initiation Yes 3b Is this a FISMA-Reportable system? 4 Does the system include a Website or online application available to and for the use of the general public? 5 Identify the operator. 6 Point of Contact (POC): 7 Is this a new or existing system? 8 Does the system have Security Authorization (SA)? 8b Planned Date of Security Authorization No Yes No Agency Contractor POC Title Epidemiologist POC Name Ryan Maddox POC Organization OID/NCEZID/DHCPP/PPHO POC Email zzp7@cdc.gov POC Phone 404-639-1170 New Existing Yes No Sep 30, 2016 Not Applicable Page 1 of 7 Save 8c Briefly explain why security authorization is not required N/A 10 Describe in further detail any changes to the system that have occurred since the last PIA. N/A 11 Describe the purpose of the system. The purpose purpose for reporting communicable diseases is to determine the prevalence of diseases dangerous to public health. Collecting this data provides the basis for planning and evaluating effective programs for prevention and control of infectious diseases. The information submitted on the disease incidences are needed to identify and study present and emerging disease problems. Patient's DOB, Age, First 3 letters of Patient's last name, Describe the type of information the system will Patient's initials, Patients Date of Death, State of Death, collect, maintain (store), or share. (Subsequent Ethnicity/Race, Patient' s State, Patient's County, Patient's Sex 12 questions will identify if this information is PII and ask and Physician contact info about the specific data elements.) This information is pulled from multiple forms. Provide an overview of the system and describe the 13 information it will collect, maintain (store), or share, either permanently or temporarily. The goal of the system is to collect disease specific surveillance reports of rare, uncommon or infrequent disease. The data will be used to determine the prevalence of diseases dangerous to public health. The data will also be used for planning and evaluating effective programs for prevention and control of infectious diseases. Disease incidence is needed to study present and emerging disease problems. Yes 14 Does the system collect, maintain, use or share PII? Indicate the type of PII that the system will collect or 15 maintain. No Social Security Number Date of Birth Name Photographic Identifiers Driver's License Number Biometric Identifiers Mother's Maiden Name Vehicle Identifiers E-Mail Address Mailing Address Phone Numbers Medical Records Number Medical Notes Financial Account Info Certificates Legal Documents Education Records Device Identifiers Military Status Employment Status Foreign Activities Passport Number Taxpayer ID Physician Contact Info. Ethnicity/Race Sex First 3 letters of last name Date of Death Page 2 of 7 Save Employees Public Citizens 16 Business Partners/Contacts (Federal, state, local agencies) Indicate the categories of individuals about whom PII is collected, maintained or shared. Vendors/Suppliers/Contractors Patients Other 17 How many individuals' PII is in the system? 18 For what primary purpose is the PII used? 19 Describe the secondary uses for which the PII will be used (e.g. testing, training or research) 5,000-9,999 The information is used for epidemiological analysis to coordinate and evaluate nationwide surveillance system of Creutzfeldt-Jakob Disease, Reye Syndrome, and Kawasaki Disease. None 20 Describe the function of the SSN. N/A 20a Cite the legal authority to use the SSN. N/A Public Health Service Act, Section 301, "Research and Identify legal authorities governing information use Investigation," (42 U.S.C. 241); and Sections 304, 306 and 308(d) 21 and disclosure specific to the system and program. Reye's Syndrome Reporting Act. 22 Yes Are records on the system retrieved by one or more PII data elements? No Published: Identify the number and title of the Privacy Act System of Records Notice (SORN) that is being used 22a to cover the system or identify if a SORN is being developed. Published: Published: In Progress Page 3 of 7 Save Directly from an individual about whom the information pertains In-Person Hard Copy: Mail/Fax Email Online Other Government Sources 23 Within the OPDIV Other HHS OPDIV State/Local/Tribal Foreign Other Federal Entities Other Identify the sources of PII in the system. Non-Government Sources Members of the Public Commercial Data Broker Public Media/Internet Private Sector Other 23a Identify the OMB information collection approval number and expiration date. OMB No. 0920-0009, Expires 04/30/2016 Yes 24 Is the PII shared with other organizations? No Within HHS Other Federal Agency/Agencies State or Local To make the States aware of the case Agency/Agencies Identify with whom the PII is shared or disclosed and 24a for what purpose. Private Sector Describe any agreements in place that authorizes the information sharing or disclosure (e.g. Computer 24b Matching Agreement, Memorandum of None Understanding (MOU), or Information Sharing Agreement (ISA)). 24c Describe the procedures for accounting for disclosures Describe the process in place to notify individuals 25 that their personal information will be collected. If no prior notice is given, explain the reason. N/A Not Applicable; At time of sample collection individuals are notified their information is being sent to the CDC by state health department staff. Individuals can choose not to write their address or their full name with the state. CDC will process the sample regardless of what information is placed on the form. Page 4 of 7 Save 26 Voluntary Is the submission of PII by individuals voluntary or mandatory? Mandatory Not Applicable: State Health departments collect this data and Describe the method for individuals to opt-out of the therefore is responsible for handling this issue. Individuals can collection or use of their PII. If there is no option to choose not to write their address or their full name. 27 object to the information collection, provide a reason. CDC will process the sample regardless of what information is placed on the form. Describe the process to notify and obtain consent from the individuals whose PII is in the system when major changes occur to the system (e.g., disclosure 28 and/or data uses have changed since the notice at the time of original collection). Alternatively, describe why they cannot be notified or have their consent obtained. Describe the process in place to resolve an individual's concerns when they believe their PII has 29 been inappropriately obtained, used, or disclosed, or that the PII is inaccurate. If no process exists, explain why not. Describe the process in place for periodic reviews of PII contained in the system to ensure the data's 30 integrity, availability, accuracy and relevancy. If no processes are in place, explain why not. None. The information is received from the state and they are responsible for handling this issue. Not applicable to CDC because the data are obtained and provided to CDC by State Health Agencies. State Health department's takes the responsibility for accurate data collecting and making the necessary changes. Annual Self -Assessment. Surveillance questions, including those related to PII, are routinely reviewed to ensure that accurate and relevant information is collected. System data are regularly analyzed, interpreted, and shared within the scientific community, which contributes to system integrity. Users Administrators 31 Identify who will have access to the PII in the system and the reason why they require access. Users enter surveillance data, including PII, into the system, analyze the data, Administrators grant system access to users. Developers Contractors Others Describe the procedures in place to determine which Only those requiring access to the system as part of their job responsibilities (i.e., users) will be granted access by system 32 system users (administrators, developers, administrators after giving authorization by Business Steward. contractors, etc.) may access PII. These users will have access to surveillance data, including PII. Describe the methods in place to allow those with 33 access to PII to only access the minimum amount of information necessary to perform their job. Identify training and awareness provided to personnel (system owners, managers, operators, contractors and/or program managers) using the 34 system to make them aware of their responsibilities for protecting the information being collected and maintained. Describe training system users receive (above and 35 beyond general security and privacy awareness training). The system has role base access to limit information accessibility. CDC Security Awareness Training N/A Page 5 of 7 Save Do contracts include Federal Acquisition Regulation 36 and other appropriate clauses ensuring adherence to privacy provisions and practices? Yes No Describe the process and guidelines in place with 37 regard to the retention and destruction of PII. Cite specific records retention schedules. Following the Scientific and Research Project Records (N1-442-09-001). Records are retained and disposed of in accordance with the CDC Records Control Schedule (N1-442-09-001). A copy of study reports are maintained in agency in accordance with retention schedules. Source documents for computer are disposed of when no longer needed by program officials. Personal identifiers may be deleted from records when no longer needed in the study as determined by the system manager, and as provided in the signed consent form, as appropriate. Disposal methods include erasing computer tapes, burning or shredding paper materials or transferring records to the Federal Records Center when no longer needed for evaluation and analysis. Records are retained for over 20 years; for longer periods if further study is needed. Describe, briefly but with specificity, how the PII will 38 be secured in the system using administrative, technical, and physical controls. Documents with PII will be secured both physically and electronically. Physical surveillance forms will be stored in locked cabinets within employee badge-secured facilities; electronic data will be saved on an encrypted network share in a folder restricted to non-users, within password-protected computer systems. REVIEWER QUESTIONS: The following section contains Reviewer Questions which are not to be filled out unless the user is an OPDIV Senior Officer for Privacy. Reviewer Questions 1 Are the questions on the PIA answered correctly, accurately, and completely? Answer Yes No Reviewer Notes 2 Does the PIA appropriately communicate the purpose of PII in the system and is the purpose justified by appropriate legal authorities? Yes Do system owners demonstrate appropriate understanding of the impact of the PII in the system and provide sufficient oversight to employees and contractors? Yes No Reviewer Notes 3 No Reviewer Notes 4 Does the PIA appropriately describe the PII quality and integrity of the data? Yes No Reviewer Notes 5 Is this a candidate for PII minimization? Yes No Page 6 of 7 Save Reviewer Questions Answer Reviewer Notes 6 Does the PIA accurately identify data retention procedures and records retention schedules? Yes No Reviewer Notes 7 Are the individuals whose PII is in the system provided appropriate participation? Yes No Reviewer Notes 8 Does the PIA raise any concerns about the security of the PII? Yes No Reviewer Notes 9 Is applicability of the Privacy Act captured correctly and is a SORN published or does it need to be? Yes No Reviewer Notes 10 Is the PII appropriately limited for use internally and with third parties? Yes No Reviewer Notes 11 Does the PIA demonstrate compliance with all Web privacy requirements? Yes No Reviewer Notes 12 Were any changes made to the system because of the completion of this PIA? Yes No Reviewer Notes General Comments OPDIV Senior Official for Privacy Signature Beverly E. Walker -S Digitally signed by Beverly E. Walker -S DN: c=US, o=U.S. Government, ou=HHS, ou=CDC, ou=People, 0.9.2342.19200300.100.1.1=100144034 3, cn=Beverly E. Walker -S Date: 2016.05.31 16:15:43 -04'00' HHS Senior Agency Official for Privacy Page 7 of 7
| File Type | application/pdf |
| File Title | AttH_PIA CID, Reye Syndrome, Kawasaki Syndrome |
| File Modified | 2016-05-31 |
| File Created | 2013-03-29 |